An integrated fecal metabolomic based on 1 H‐NMR and UPLC‐QTOF‐MS revealed the preventive mechanism of Gushudan on glucocorticoid‐induced osteoporotic rats
Biomedical Chromatography · 2023
DOI: 10.1002/bmc.5693 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2023. Verfasst von Ling Xin und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shenyang Pharmaceutical University, Benxi, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Osteoporosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: National Natural Science Foundation of China under Grant No. 82174235 and Grant No.81773694, Science foundation of Shenyang Pharmaceutical University under Grant No. GGJJ2021107.
Abstract (Originalsprache)
Gushudan (GSD) has the effect of strengthening bones and nourishing kidneys. However, its specific intervention mechanism still remains unclear. In this study, to investigate the pathogenesis of glucocorticoid‐induced osteoporosis (GIOP) and the preventive mechanism of GSD on GIOP, fecal metabolomics based on 1 H‐NMR and ultra‐high‐performance liquid chromatography‐quadrupole time‐of‐flight‐mass spectrometry method was established. The changes in endogenous metabolites and the relevant metabolic pathways in the control group, model group, and GSD treatment group were investigated via multivariate statistical analysis. As a result, a total of 39 differential metabolites were identified. Of these, 22 metabolites, such as L‐methionine , guanine, and sphingosine, were newly discovered as differential metabolites of GIOP. Amino acid metabolism, energy metabolism, intestinal flora metabolism, and lipid metabolism were significantly changed in the fecal profiles of GIOP rats, and GSD could play an anti‐osteoporosis role by regulating these metabolic pathways. Finally, compared with our previous study of the GSD to prevent kidney yang deficiency syndrome, this study suggested that there were some identical differential metabolites and metabolic pathways. It showed that there was some correlation among the metabolic profiles of the intestine, kidney, and bone in GIOP rats. Therefore, this study offered new insights into the in‐depth understanding of the pathogenesis of GIOP and the intervention mechanism of GSD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Shenyang Pharmaceutical University, Benxi, China.
- School of Life Sciences and Biopharmaceutical Science, Shenyang Pharmaceutical University, Shenyang, China.
ORCID-Profile: Longshan Zhao, Zhili Xiong
Förderung
- National Natural Science Foundation of China under Grant No. 82174235 and Grant No.81773694
- Science foundation of Shenyang Pharmaceutical University under Grant No. GGJJ2021107
Zitieren
APA
Xin, L., Liu, S., Lou, Y., Zhang, J., Lu, Q., Zhao, L., Wei, X., & Xiong, Z. (2023). An integrated fecal metabolomic based on 1 H‐NMR and UPLC‐QTOF‐MS revealed the preventive mechanism of Gushudan on glucocorticoid‐induced osteoporotic rats. Biomedical Chromatography. https://doi.org/10.1002/bmc.5693
Vancouver
Xin L, Liu S, Lou Y, Zhang J, Lu Q, Zhao L, et al. An integrated fecal metabolomic based on 1 H‐NMR and UPLC‐QTOF‐MS revealed the preventive mechanism of Gushudan on glucocorticoid‐induced osteoporotic rats. Biomedical Chromatography. 2023. doi:10.1002/bmc.5693
BibTeX
@article{Xin2023,
author = {Xin, Ling and Liu, Shuo and Lou, Yanwei and Zhang, Jing and Lu, Qing and Zhao, Longshan and Wei, Xiuyan and Xiong, Zhili},
title = {An integrated fecal metabolomic based on 1 H‐NMR and UPLC‐QTOF‐MS revealed the preventive mechanism of Gushudan on glucocorticoid‐induced osteoporotic rats},
journal = {Biomedical Chromatography},
year = {2023},
doi = {10.1002/bmc.5693}
}
EUVIMED